MA
IDXX icon

MJP Associates’s Idexx Laboratories IDXX Stock Holding History

MJP Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-860
Closed -$434K – 240
2024
Q3 		$434K Sell
860
-138
-14% -$67K 0.08% 125
2024
Q2 		$486K Buy
998
+45
+5% +$22.6K 0.1% 107
2024
Q1 		$515K Buy
953
+230
+32% +$126K 0.11% 98
2023
Q4 		$401K Buy
723
+81
+13% +$38K 0.11% 93
2023
Q3 		$281K Buy
642
+136
+27% +$67.8K 0.08% 111
2023
Q2 		$254K Buy
506
+73
+17% +$35K 0.08% 118
2023
Q1 		$217K Buy
+433
New +$207K 0.07% 124
2022
Q2 		– Sell
-385
Closed -$211K – 148
2022
Q1 		$211K Sell
385
-113
-23% -$59.4K 0.05% 148
2021
Q4 		$314K Buy
498
+91
+22% +$57.1K 0.09% 105
2021
Q3 		$253K Buy
407
+8
+2% +$5.38K 0.09% 113
2021
Q2 		$252K Sell
399
-22
-5% -$12.1K 0.08% 112
2021
Q1 		$206K Buy
+421
New +$211K 0.08% 122

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MJP Associates's IDXX Position: Q4 2024 in Review

MJP Associates sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 860 shares — an estimated $434K sold.

MJP Associates first reported a position in IDXX in Q1 2021 and held it in 12 quarters. The position peaked at $515K in Q1 2024. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • MJP Associates reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • MJP Associates sold 860 Idexx Laboratories shares in Q4 2024, an estimated $434K.
  • MJP Associates first reported a position in Idexx Laboratories in Q1 2021 and held it in 12 quarters.
  • MJP Associates's Idexx Laboratories position peaked at $515K in Q1 2024.
  • 1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on MJP Associates's 13F filing for Q4 2024, filed 14 Feb 2025.